Discussion on the Clinical Effect of Bifidobacterium Lactis Triple-activated bacterial Tablets Combined with Mosapride Citrate Tablets on Children with Functional Dyspepsia
Objective To investigate the therapeutic effect of clinical application of Bifidobacterium lactis triple-activated bacterial tablets and mosapride citrate tablets in the combined treatment of children with functional dyspep-sia.Methods A total of 165 children with functional dyspepsia admitted to the Affiliated Hospital of Putian College from January 2021 to June 2023 were conveniently selected as the study objects and divided into 3 groups with 55 cases in each group by random number table method.Group A was treated with Bifidobacterium lactis triple-activated bacterial tablets,group B was treated with mosapride citrate tablets,and the combined group was treated with a combi-nation of group A and group B drugs.The therapeutic effect,gastrointestinal function level and the occurrence of ad-verse reactions were compared among the three groups.Results The total effective rate of combined group was 95.00%,which was higher than 77.50% in group A and 80.00% in group B,and the differences were statistically sig-nificant(χ2=4.949,3.960,both P<0.05).After treatment,the improvement effect of gastrointestinal function in com-bined group was better than that in group A and group B,and the differences were statistically significant(both P<0.05).There were no significant differences in the total incidence of adverse reactions among the three groups(both P>0.05).Conclusion Combining the treatment of Bifidobacterium lactis triple-activated bacterial tablets with mosapride citrate tablets may help to improve the clinical efficacy,improve the level of gastrointestinal function,and have a cer-tain degree of safety.
NETL
NSTL
万方数据
